“In this report, the global clinical microbiology market is segmented on the basis of products and applications. On the basis of products, the clinical microbiology market is segmented into consumables and instruments. Each of these market segments is further divided into multiple product segments and subsegments. The clinical microbiology consumables is further bifurcated into kits and reagents, whereas the clinical microbiology instruments market is segmented into automated microbiology instruments, laboratory instruments, and microbiology analyzers. The laboratory instruments are further categorized into anaerobic gas systems, automated gram stainers, automated petri dish fillers, autoclave sterilizers, bacterial colony counters, incubators, microbial air samplers, and other laboratory instruments; whereas the microbiology analyzers are further categorized into mass spectrometers, microscopes, and molecular diagnostics instruments.
Clinical microbiology has applications in a large number of infectious diseases. On the basis of applications, the report is segmented into bloodstream infections, gastrointestinal diseases, periodontal diseases, respiratory diseases, sexually transmitted diseases, urinary tract infections, and other diseases. The geographic segments included in this report are Asia, Europe, North America, and Rest of the World.
The large disease burden of infectious diseases is the key growth driver for this market. The outbreak of new diseases has further aided the growth of this market. The growing trend of laboratory automation and the increase in access to medical insurance in the U.S. market will aid the growth of this market. Moreover, increased healthcare expenditure will drive the growth of this market.
In this report, a combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates. Secondary information was used to identify the overall revenue, geographic reach, and product portfolios of the market players. Estimates of their clinical microbiology segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.
The report provides qualitative insights about the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. Moreover, the report provides a competitive landscape of the clinical microbiology market. The competitive landscape covers the growth strategies adopted by industry players over the last three years such as mergers and acquisitions, agreements and partnerships, and new product launches.
 
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
The report provides insights on the following:
• Product Development/Innovation: Product portfolios of the top players in the clinical microbiology market. Insights on upcoming technologies, research and development activities, and new product launches in the clinical microbiology market
• Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the clinical microbiology market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various clinical microbiology products across geographies
• Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the clinical microbiology market
”
“TABLE OF CONTENTS
1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED IN THE REPORT 20
1.4 CURRENCY 20
1.5 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 MARKET SIZE ESTIMATION 23
2.2 MARKET CRACKDOWN AND DATA TRIANGULATION 25
2.3 MARKET SHARE ESTIMATION 26
2.3.1 KEY DATA FROM SECONDARY SOURCES 27
2.3.2 KEY DATA FROM PRIMARY SOURCES 27
2.3.3 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 34
4.1 LUCRATIVE OPPORTUNITIES IN THE GLOBAL CLINICAL MICROBIOLOGY MARKET 34
4.2 LIFE CYCLE ANALYSIS, BY REGION 35
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 MICROBIOLOGY MARKET BY APPLICATIONS 38
5.2.2 CLINICAL MICROBIOLOGY MARKET BY PRODUCT 39
5.2.3 CLINICAL MICROBIOLOGY MARKET BY APPLICATION 39
5.3 MARKET DYNAMICS 40
5.3.1 DRIVERS 40
5.3.1.1 High burden of infectious diseases 40
5.3.1.2 Increasing healthcare expenditure 41
5.3.1.3 Large number of outbreaks of new diseases and rising incidence of infectious diseases 42
5.3.1.4 Increase in access to medical insurance in the U.S. market will aid the growth of the clinical microbiology market 42
5.3.2 RESTRAINTS 44
5.3.2.1 Stringent regulatory policies for medical devices to restrain market growth 44
5.3.2.2 Reimbursement Issues 44
5.3.3 OPPORTUNITIES 45
5.3.3.1 Increased demand for applied markets and improved diagnostic capabilities 45
5.3.3.2 Emerging markets present significant opportunities for clinical microbiology 45
5.3.4 TRENDS 46
5.3.4.1 Quick turnaround times 46
5.3.4.2 Demand for automation 47
6 INDUSTRY INSIGHTS 48
6.1 INTRODUCTION 48
6.2 PORTER’S FIVE FORCES ANALYSIS 48
6.2.1 THREAT FROM NEW ENTRANTS 48
6.2.2 THREAT FROM SUBSTITUTES 49
6.2.3 BARGAINING POWER OF BUYERS 49
6.2.4 BARGAINING POWER OF SUPPLIERS 49
6.2.5 INTENSITY OF RIVALRY 49
6.3 STRATEGIC BENCHMARKING 50
6.4 SUPPLY CHAIN ANALYSIS 50
6.4.1 KEY INFLUENCERS 51
7 MICROBIOLOGY MARKET, BY APPLICATIONS 52
7.1 INTRODUCTION 53
7.2 PHARMACEUTICAL 54
7.3 CLINICAL 55
7.4 FOOD 57
7.5 ENERGY 58
7.6 MANUFACTURING 60
7.7 ENVIRONMENT 61
8 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT 63
8.1 INTRODUCTION 64
8.2 INSTRUMENTS 65
8.2.1 LABORATORY INSTRUMENTS 67
8.2.1.1 Incubators 68
8.2.1.2 Automated Gram Stainers 69
8.2.1.3 Bacterial Colony Counters 70
8.2.1.4 Autoclave Sterilizers 71
8.2.1.5 Microbial Air Samplers 72
8.2.1.6 Anaerobic Gas Systems 73
8.2.1.7 Automated Petri Dish Fillers 74
8.2.1.8 Other Laboratory Instruments 75
8.2.2 AUTOMATED MICROBIOLOGY INSTRUMENTS 76
8.2.3 MICROBIOLOGY ANALYZERS 77
8.2.3.1 Molecular Diagnostic Instruments 79
8.2.3.2 Microscopes 80
8.2.3.3 Mass Spectrometers 81
8.3 CONSUMABLES 83
8.3.1 KITS 84
8.3.2 REAGENTS 85
9 CLINICAL MICROBIOLOGY MARKET, BY APPLICATIONS 87
9.1 INTRODUCTION 88
9.2 RESPIRATORY DISEASES 89
9.3 BLOODSTREAM INFECTIONS 90
9.4 GASTROINTESTINAL DISEASES 92
9.5 SEXUALLY TRANSMITTED DISEASES 93
9.6 URINARY TRACT INFECTIONS 94
9.7 PERIODONTAL DISEASES 96
9.8 OTHER DISEASES 97
10 CLINICAL MICROBIOLOGY MARKET, BY GEOGRAPHY 99
10.1 INTRODUCTION 100
10.2 NORTH AMERICA 102
10.3 EUROPE 111
10.4 ASIA 118
10.5 REST OF THE WORLD 127
11 COMPETITIVE LANDSCAPE 135
11.1 OVERVIEW 135
11.2 MARKET SHARE ANALYSIS, CLINICAL MICROBIOLOGY MARKET 135
11.3 COMPETITIVE SITUATION AND TRENDS 137
11.3.1 NEW PRODUCT LAUNCHES 137
11.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 139
11.3.3 ACQUISITIONS AND DIVESTITURES 140
11.3.4 EXPANSIONS 141
11.3.5 OTHER DEVELOPMENTS 142
12 COMPANY PROFILES 144
12.1 INTRODUCTION 144
12.2 BECTON, DICKINSON AND COMPANY 145
12.3 BIOMÉRIEUX SA 151
12.4 CEPHEID 157
12.5 DANAHER CORPORATION 162
12.6 SIEMENS AG 166
12.7 ABBOTT LABORATORIES, INC. 170
12.8 ALERE, INC. 174
12.9 BIO-RAD LABORATORIES, INC. 178
12.10 BRUKER CORPORATION 181
12.11 F. HOFFMANN-LA ROCHE LTD. 185
12.12 HOLOGIC, INC. 189
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
13 APPENDIX 192
13.1 INSIGHTS OF INDUSTRY EXPERTS 192
13.2 DISCUSSION GUIDE 193
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 196
13.4 AVAILABLE CUSTOMIZATIONS 198
13.5 RELATED REPORTS 199
“
“LIST OF TABLES
TABLE 1 TOP TEN HUMAN DISEASE OUTBREAKS DURING 2000 TO 2010 42
TABLE 2 HIGH BURDEN OF INFECTIOUS DISEASES IS PROPELLING THE GROWTH OF CLINICAL MICROBIOLOGY MARKET 43
TABLE 3 STRINGENT REGULATORY POLICIES FOR MEDICAL DEVICES IS HINDERING MARKET GROWTH 44
TABLE 4 INCREASED DEMAND FOR APPLIED MARKETS AND IMPROVED DIAGNOSTIC CAPABILITIES ARE PAVING NEW GROWTH AVENUES FOR PLAYERS IN THE CLINICAL MICROBIOLOGY MARKET 46
TABLE 5 MARKET DEVELOPMENTS BETWEEN 2010 AND 2014 50
TABLE 6 MICROBIOLOGY MARKET, BY APPLICATION, 2012–2019 ($MILLION) 53
TABLE 7 PRODUCTION OF SOME STEROIDS USING MICROORGANISMS 54
TABLE 8 MICROBIOLOGY MARKET SIZE FOR PHARMACEUTICAL APPLICATIONS, BY REGION,
2012–2019 ($MILLION) 55
TABLE 9 MICROBIOLOGY MARKET FOR CLINICAL APPLICATIONS, BY REGION,
2012–2019 ($MILLION) 56
TABLE 10 FLAVORS AND FRAGRANCES PRODUCED BY SOME MICROORGANISMS OR USING ENZYMES 57
TABLE 11 MICROBIOLOGY MARKET SIZE FOR FOOD APPLICATION, BY REGION,
2012–2019 ($MILLION) 58
TABLE 12 MICROBIOLOGY MARKET FOR ENERGY APPLICATIONS, BY REGION,
2012–2019 ($MILLION) 60
TABLE 13 MICROBIOLOGY MARKET SIZE FOR MANUFACTURING APPLICATION, BY REGION,
2012–2019 ($MILLION) 61
TABLE 14 MICROBIOLOGY MARKET SIZE FOR ENVIRONMENT APPLICATION, BY REGION,
2012–2019 ($MILLION) 62
TABLE 15 CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 64
TABLE 16 CLINICAL MICROBIOLOGY MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2012–2019 ($MILLION) 65
TABLE 17 CLINICAL MICROBIOLOGY MARKET SIZE FOR INSTRUMENTS, BY REGION,
2012–2019 ($MILLION) 66
TABLE 18 CLINICAL MICROBIOLOGY MARKET SIZE FOR LABORATORY INSTRUMENTS,
BY TYPE, 2012–2019 ($MILLION) 67
TABLE 19 CLINICAL MICROBIOLOGY MARKET SIZE FOR LABORATORY INSTRUMENTS,
BY REGION, 2012–2019 ($MILLION) 68
TABLE 20 CLINICAL MICROBIOLOGY MARKET SIZE FOR INCUBATORS, BY REGION,
2012–2019 ($MILLION) 69
TABLE 21 CLINICAL MICROBIOLOGY MARKET SIZE FOR AUTOMATED GRAM STAINERS,
BY REGION, 2012–2019 ($MILLION) 70
TABLE 22 CLINICAL MICROBIOLOGY MARKET SIZE FOR BACTERIAL COLONY COUNTERS,
BY REGION, 2012–2019 ($MILLION) 71
TABLE 23 CLINICAL MICROBIOLOGY MARKET SIZE FOR AUTOCLAVE STERILIZERS,
BY REGION, 2012–2019 ($MILLION) 72
TABLE 24 CLINICAL MICROBIOLOGY MARKET SIZE FOR MICROBIAL AIR SAMPLERS,
BY REGION, 2012–2019 ($MILLION) 73
TABLE 25 CLINICAL MICROBIOLOGY MARKET SIZE FOR ANAEROBIC GAS SYSTEMS,
BY REGION, 2012–2019 ($MILLION) 74
TABLE 26 CLINICAL MICROBIOLOGY MARKET SIZE FOR AUTOMATED PETRI DISH FILLERS,
BY REGION, 2012–2019 ($MILLION) 75
TABLE 27 CLINICAL MICROBIOLOGY MARKET SIZE FOR OTHER LABORATORY INSTRUMENTS,
BY REGION, 2012–2019 ($MILLION) 76
TABLE 28 CLINICAL MICROBIOLOGY MARKET SIZE FOR AUTOMATED MICROBIOLOGY INSTRUMENTS, BY REGION, 2012–2019 ($MILLION) 77
TABLE 29 CLINICAL MICROBIOLOGY MARKET SIZE FOR MICROBIOLOGY ANALYZERS,
BY TYPE, 2012–2019 ($MILLION) 78
TABLE 30 CLINICAL MICROBIOLOGY MARKET SIZE FOR MICROBIOLOGY ANALYZERS,
BY REGION, 2012–2019 ($MILLION) 79
TABLE 31 CLINICAL MICROBIOLOGY MARKET SIZE FOR MOLECULAR DIAGNOSTIC INSTRUMENTS, BY REGION, 2012–2019 ($MILLION) 80
TABLE 32 CLINICAL MICROBIOLOGY MARKET SIZE FOR MICROSCOPES, BY REGION,
2012–2019 ($MILLION) 81
TABLE 33 CLINICAL MICROBIOLOGY MARKET SIZE FOR MASS SPECTROMETERS, BY REGION, 2012–2019 ($MILLION) 82
TABLE 34 CLINICAL MICROBIOLOGY MARKET SIZE FOR CONSUMABLES, BY TYPE,
2012–2019 ($MILLION) 83
TABLE 35 CLINICAL MICROBIOLOGY MARKET SIZE FOR CONSUMABLES, BY REGION,
2012–2019 ($MILLION) 84
TABLE 36 CLINICAL MICROBIOLOGY MARKET SIZE FOR KITS, BY REGION,
2012–2019 ($MILLION) 85
TABLE 37 CLINICAL MICROBIOLOGY MARKET SIZE FOR REAGENTS, BY REGION,
2012–2019 ($MILLION) 86
TABLE 38 CLINICAL MICROBIOLOGY MARKET, BY APPLICATION, 2012–2019 ($MILLION) 89
TABLE 39 CLINICAL MICROBIOLOGY MARKET SIZE FOR RESPIRATORY DISEASES, BY REGION, 2012–2019 ($MILLION) 90
TABLE 40 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION,
2012–2019 ($MILLION) 91
TABLE 41 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES,
BY REGION, 2012–2019 ($MILLION) 93
TABLE 42 CLINICAL MICROBIOLOGY MARKET SIZE FOR STDS, BY REGION,
2012–2019 ($MILLION) 94
TABLE 43 PRIMARY CAUSATIVE ORGANISMS OF URINARY TRACT INFECTIONS 95
TABLE 44 CLINICAL MICROBIOLOGY MARKET SIZE FOR UTIS, BY REGION,
2012–2019 ($MILLION) 96
TABLE 45 CLINICAL MICROBIOLOGY MARKET SIZE FOR PERIODONTAL DISEASES, BY REGION, 2012–2019 ($MILLION) 97
TABLE 46 CLINICAL MICROBIOLOGY MARKET SIZE FOR OTHER DISEASES, BY REGION,
2012–2019 ($MILLION) 98
TABLE 47 MICROBIOLOGY MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 101
TABLE 48 CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 102
TABLE 49 NORTH AMERICA: MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 105
TABLE 50 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 106
TABLE 51 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 107
TABLE 52 NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE,
BY TYPE, 2012–2019 ($MILLION) 108
TABLE 53 NORTH AMERICA: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 109
TABLE 54 NORTH AMERICA: CLINICAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 110
TABLE 55 NORTH AMERICA: CLINICAL MICROBIOLOGY CONSUMABLES MARKET SIZE,
BY TYPE, 2012–2019 ($MILLION) 111
TABLE 56 EUROPE: MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION) 113
TABLE 57 EUROPE: CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 114
TABLE 58 EUROPE: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 115
TABLE 59 EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 115
TABLE 60 EUROPE: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE,
BY TYPE, 2012–2019 ($MILLION) 116
TABLE 61 EUROPE: CLINICAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 117
TABLE 62 EUROPE: CLINICAL MICROBIOLOGY CONSUMABLES MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 118
TABLE 63 ASIA: MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2014 VS. 2019 ($MILLION) 121
TABLE 64 ASIA: MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION) 121
TABLE 65 ASIA: CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 122
TABLE 66 ASIA: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 123
TABLE 67 ASIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 124
TABLE 68 ASIA: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE,
BY TYPE, 2012–2019 ($MILLION) 125
TABLE 69 ASIA: CLINICAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 126
TABLE 70 ASIA: CLINICAL MICROBIOLOGY CONSUMABLES MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 127
TABLE 71 ROW: MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION) 128
TABLE 72 ROW: CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2012–2019 ($MILLION) 129
TABLE 73 ROW: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 130
TABLE 74 ROW: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 131
TABLE 75 ROW: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE,
BY TYPE, 2012–2019 ($MILLION) 132
TABLE 76 ROW: CLINICAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 133
TABLE 77 ROW: CLINICAL MICROBIOLOGY CONSUMABLES MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 134
TABLE 78 NEW PRODUCT LAUNCHES, 2011–2014 138
TABLE 79 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2011–2014 139
TABLE 80 ACQUISITIONS AND DIVESTITURES, 2011–2014 140
TABLE 81 EXPANSIONS, 2011–2014 141
TABLE 82 OTHER DEVELOPMENTS, 2011–2014 142
“
“LIST OF FIGURES
FIGURE 1 CLINICAL MICROBIOLOGY MARKET 20
FIGURE 2 RESEARCH METHODOLOGY 22
FIGURE 3 BOTTOM-UP APPROACH 24
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 24
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 25
FIGURE 6 DATA TRIANGULATION METHODOLOGY 26
FIGURE 7 CONSUMABLES ARE EXPECTED TO BE THE FASTEST-GROWING PRODUCT SEGMENT IN THE FORECAST PERIOD 29
FIGURE 8 AUTOMATED MICROBIOLOGY INSTRUMENTS ARE EXPECTED TO BE THE FASTEST-GROWING INSTRUMENTS SEGMENT IN THE FORECAST PERIOD 30
FIGURE 9 INCUBATORS ARE EXPECTED TO BE THE LARGEST AND FASTEST-GROWING LABORATORY INSTRUMENTS SEGMENT IN THE FORECAST PERIOD 30
FIGURE 10 MOLECULAR DIAGNOSTICS INSTRUMENTS WILL BE THE LARGEST MICROBIOLOGY ANALYZERS SEGMENT IN THE FORECAST PERIOD (2014–2019) 31
FIGURE 11 KITS ARE EXPECTED TO BE LARGEST AND FASTEST-GROWING CONSUMABLES SEGMENT IN THE FORECAST PERIOD 31
FIGURE 12 PHARMACEUTICAL APPLICATIONS DOMINATES MICROBIOLOGY MARKET 32
FIGURE 13 RESPIRATORY DISEASES EXPECTED TO BE THE LARGEST AND FASTEST GROWING APPLICATION SEGMENT 32
FIGURE 14 ASIA EXPECTED TO GROW AT THE HIGHEST RATE IN THE GLOBAL MICROBIOLOGY MARKET DURING THE FORECAST PERIOD (2014–2019) 33
FIGURE 15 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE IN THE CLINICAL MICROBIOLOGY MARKET DURING THE FORECAST PERIOD (2014–2019) 33
FIGURE 16 INCREASE IN INCIDENCE OF INFECTIOUS DISEASES WILL DRIVE THE MARKET 34
FIGURE 17 CLINICAL MICROBIOLOGY INSTRUMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE (2014) 34
FIGURE 18 ASIA TO SHOW FASTEST GROWTH IN THE FORECAST PERIOD (2014 TO 2019) 35
FIGURE 19 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES 35
FIGURE 20 MICROBIOLOGY MARKET SEGMENTATION: BY APPLICATIONS 38
FIGURE 21 CLINICAL MICROBIOLOGY MARKET SEGMENTATION: BY PRODUCT 39
FIGURE 22 CLINICAL MICROBIOLOGY MARKET SEGMENTATION: BY APPLICATIONS 39
FIGURE 23 HIGH PREVALENCE OF INFECTIOUS DISEASES AND OUTBREAK OF NEW DISEASES TO DRIVE THE CLINICAL MICROBIOLOGY MARKET 40
FIGURE 24 THE HIGH BURDEN OF INFECTIOUS DISEASES IS AN IMPORTANT CAUSE OF DISABILITY-ADJUSTED LIFE YEARS 41
FIGURE 25 INCREASING HEALTHCARE EXPENDITURE THE MOST IMPORTANT DRIVER OF THE CLINICAL MICROBIOLOGY MARKET 41
FIGURE 26 GROWTH IN HEALTHCARE EXPENDITURE IN ASIA AND ROW OUTPACING THAT OF NORTH AMERICA AND EUROPE 45
FIGURE 27 HIGH CAPITAL INVESTMENT TO RESTRICT ENTRY OF NEW PLAYERS 48
FIGURE 28 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES 51
FIGURE 29 MICROBIOLOGY MARKET, BY APPLICATIONS 53
FIGURE 30 FOOD WILL BE FASTEST-GROWING APPLICATION SEGMENT 53
FIGURE 31 NORTH AMERICA DOMINATES THE MICROBIOLOGY MARKET FOR PHARMACEUTICALS 55
FIGURE 32 NORTH AMERICA COMMANDS THE LARGEST SHARE OF CLINICAL APPLICATION, OWING TO INCREASED ACCESS TO MEDICAL INSURANCE 56
FIGURE 33 FOOD APPLICATION SEGMENT TO WITNESS HIGHEST GROWTH RATE IN ASIA 58
FIGURE 34 ASIA EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT FOR ENERGY APPLICATIONS 59
FIGURE 35 INCREASED USE OF BIODEGRADABLE MATERIALS TO DRIVE GROWTH OF MANUFACTURING APPLICATION MARKET SEGMENT 61
FIGURE 36 NORTH AMERICA ACCOUNTED FOR THE LARGEST SEGMENT OF ENVIRONMENTAL APPLICATIONS IN 2014 62
FIGURE 37 CONSUMABLES TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 64
FIGURE 38 LABORATORY INSTRUMENTS TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY INSTRUMENTS MARKET IN 2014 65
FIGURE 39 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS 66
FIGURE 40 INCUBATORS TO HOLD LARGEST SHARE OF MARKET FOR LABORATORY INSTRUMENTS 67
FIGURE 41 NORTH AMERICA DOMINATES THE CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS 68
FIGURE 42 NORTH AMERICA DOMINATES THE CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS 69
FIGURE 43 ASIAN MARKET FOR GRAM STAINERS EXPECTED TO GROW AT A HIGHEST CAGR 70
FIGURE 44 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF BACTERIAL COLONY COUNTERS IN 2014 71
FIGURE 45 NORTH AMERICA EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF AUTOCLAVE STERILIZERS MARKET DURING THE FORECAST PERIOD 72
FIGURE 46 ASIA IS EXPECTED TO GROW AT THE HIGHEST CAGR FOR MICROBIAL AIR SAMPLERS DURING THE FORECAST PERIOD 73
FIGURE 47 NORTH AMERICA DOMINATES THE CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC GAS SYSTEMS 74
FIGURE 48 ASIAN AUTOMATED PETRI DISH FILLERS SEGMENT EXPECTED TO SHOW HIGHEST GROWTH 75
FIGURE 49 NORTH AMERICA DOMINATES CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS 76
FIGURE 50 AUTOMATED MICROBIOLOGY INSTRUMENTS EXPECTED TO BE THE FASTEST-GROWING SEGMENT OF THE INSTRUMENTS MARKET 77
FIGURE 51 MOLECULAR DIAGNOSTIC INSTRUMENTS TO COMMAND THE LARGEST SHARE OF MICROBIOLOGY ANALYZERS MARKET 78
FIGURE 52 NORTH AMERICA DOMINATES CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS 79
FIGURE 53 NORTH AMERICA DOMINATES MARKET FOR MOLECULAR DIAGNOSTIC INSTRUMENTS 80
FIGURE 54 ASIAN REGIONAL SEGMENT TO SHOW HIGHEST GROWTH RATE IN THE CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES 81
FIGURE 55 NORTH AMERICA DOMINATES CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS 82
FIGURE 56 KITS TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY MARKET FOR CONSUMABLES 83
FIGURE 57 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY MARKET FOR CONSUMABLES 84
FIGURE 58 NORTH AMERICA DOMINATES THE CLINICAL MICROBIOLOGY MARKET FOR KITS 85
FIGURE 59 ASIAN SEGMENT EXPECTED TO GROW AT THE HIGHEST CAGR IN MARKET FOR REAGENTS 86
FIGURE 60 CLINICAL MICROBIOLOGY MARKET, BY APPLICATIONS 88
FIGURE 61 RESPIRATORY DISEASES WILL BE FASTEST-GROWING APPLICATION IN MICROBIOLOGY MARKET 88
FIGURE 62 NORTH AMERICA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF RESPIRATORY DISEASES SEGMENT 90
FIGURE 63 NORTH AMERICA ACCOUNTS FOR THE LARGEST MARKET SHARE IN 2014 91
FIGURE 64 HIGH PREVALENCE OF GASTROINTESTINAL DISEASES IN CHILDREN TO DRIVE THE MARKET 92
FIGURE 65 INCREASING NUMBER OF HIV INFECTIONS TO DRIVE THE MARKET 94
FIGURE 66 ASIA IS EXPECTED TO GROW WITH THE HIGHEST CAGR DURING THE FORECAST PERIOD 95
FIGURE 67 INCREASED PREVALENCE OF PERIODONTITIS TO DRIVE THE MARKET 97
FIGURE 68 PREVALENCE OF SKIN DISEASES IN UNDER DEVELOPED REGIONS TO DRIVE THE MARKET 98
FIGURE 69 MARKET IN ASIA EXPECTED TO GROW AT HIGHEST RATE FROM 2014 TO 2019 100
FIGURE 70 MICROBIOLOGY MARKET SIZE, BY REGION, 2014 VS. 2019 ($MILLION) 101
FIGURE 71 CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2014 VS. 2019 ($MILLION) 102
FIGURE 72 NORTH AMERICA: MARKET SNAPSHOT 104
FIGURE 73 NORTH AMERICA: MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2014 VS. 2019 ($MILLION) 105
FIGURE 74 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2014 VS. 2019 ($MILLION) 106
FIGURE 75 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT,
2014 VS. 2019 ($MILLION) 107
FIGURE 76 NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE,
BY TYPE, 2014 VS. 2019 ($MILLION) 108
FIGURE 77 NORTH AMERICA: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE, BY TYPE, 2014 VS. 2019 ($MILLION) 109
FIGURE 78 NORTH AMERICA: CLINICAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE, 2014 VS. 2019 ($MILLION) 110
FIGURE 79 NORTH AMERICA: CLINICAL MICROBIOLOGY CONSUMABLES MARKET SIZE,
BY TYPE, 2014 VS. 2019 ($MILLION) 111
FIGURE 80 EUROPE: MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2014 VS. 2019 ($MILLION) 112
FIGURE 81 EUROPE: CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2014 VS. 2019 ($MILLION) 113
FIGURE 82 EUROPE: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT,
2014 VS. 2019 ($MILLION) 114
FIGURE 83 EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 115
FIGURE 84 EUROPE: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE,
BY TYPE, 2014 VS. 2019 ($MILLION) 116
FIGURE 85 EUROPE: CLINICAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 117
FIGURE 86 EUROPE: CLINICAL MICROBIOLOGY CONSUMABLES MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 118
FIGURE 87 ASIA: MARKET SNAPSHOT 120
FIGURE 88 ASIA: CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2014 VS. 2019 ($MILLION) 122
FIGURE 89 ASIA: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT,
2014 VS. 2019 ($MILLION) 123
FIGURE 90 ASIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 124
FIGURE 91 ASIA: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE,
BY TYPE, 2014 VS. 2019 ($MILLION) 125
FIGURE 92 ASIA: CLINICAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 126
FIGURE 93 ASIA: CLINICAL MICROBIOLOGY CONSUMABLES MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 127
FIGURE 94 ROW: MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2014 VS. 2019 ($MILLION) 128
FIGURE 95 ROW: CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION,
2014 VS. 2019 ($MILLION) 129
FIGURE 96 ROW: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT,
2014 VS. 2019 ($MILLION) 130
FIGURE 97 ROW: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 131
FIGURE 98 ROW: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE,
BY TYPE, 2014 VS. 2019 ($MILLION) 132
FIGURE 99 ROW: CLINICAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 133
FIGURE 100 ROW: CLINICAL MICROBIOLOGY CONSUMABLES MARKET SIZE, BY TYPE,
2014 VS. 2019 ($MILLION) 134
FIGURE 101 NEW PRODUCT LAUNCH IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS 135
FIGURE 102 CLINICAL MICROBIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 136
FIGURE 103 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY 137
FIGURE 104 NEW PRODUCT LAUNCHES, 2011–2014 138
FIGURE 105 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2011–2014 139
FIGURE 106 ACQUISITIONS AND DIVESTITURES, 2011–2014 140
FIGURE 107 EXPANSIONS, 2011–2014 141
FIGURE 108 OTHER DEVELOPMENTS, 2011–2014 142
FIGURE 109 GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS 144
FIGURE 110 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 145
FIGURE 111 BIOMÉRIEUX SA: COMPANY SNAPSHOT 151
FIGURE 112 CEPHEID: COMPANY SNAPSHOT 157
FIGURE 113 DANAHER CORPORATION: COMPANY SNAPSHOT 162
FIGURE 114 SIEMENS AG: COMPANY SNAPSHOT 166
FIGURE 115 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT 170
FIGURE 116 ALERE, INC.: COMPANY SNAPSHOT 174
FIGURE 117 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 178
FIGURE 118 BRUKER CORPORATION: COMPANY SNAPSHOT 181
FIGURE 119 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 185
FIGURE 120 HOLOGIC, INC.: COMPANY SNAPSHOT 189
“
